Atika Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,500
| Closed | -$8.94M | – | 100 |
|
|
2024
Q3 | $8.94M | Sell |
8,500
-1,000
| -11% | -$1.05M | 0.92% | 39 |
|
|
2024
Q2 | $9.98M | Buy |
9,500
+700
| +8% | +$736K | 0.98% | 30 |
|
|
2024
Q1 | $8.47M | Buy |
+8,800
| New | +$8.47M | 0.83% | 42 |
|
|
2023
Q2 | – | Sell |
-9,690
| Closed | -$7.96M | – | 89 |
|
|
2023
Q1 | $7.96M | Buy |
+9,690
| New | +$7.96M | 1.18% | 29 |
|
|
2020
Q4 | – | Sell |
-14,200
| Closed | -$7.95M | – | 119 |
|
|
2020
Q3 | $7.95M | Buy |
14,200
+1,700
| +14% | +$952K | 0.65% | 46 |
|
|
2020
Q2 | $7.8M | Buy |
12,500
+9,453
| +310% | +$5.9M | 1.01% | 36 |
|
|
2020
Q1 | $1.49M | Buy |
+3,047
| New | +$1.49M | 0.29% | 65 |
|
|
2017
Q3 | – | Sell |
-9,500
| Closed | -$4.67M | – | 77 |
|
|
2017
Q2 | $4.67M | Buy |
9,500
+2,500
| +36% | +$1.23M | 1.63% | 14 |
|
|
2017
Q1 | $2.71M | Buy |
+7,000
| New | +$2.71M | 1.33% | 36 |
|